EyePoint Pharmaceuticals (EYPT)
(Real Time Quote from BATS)
$8.62 USD
-0.13 (-1.49%)
Updated Aug 12, 2024 02:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -0.57 |
EPS Last Quarter | -0.58 |
Last EPS Surprise | -5.45% |
ABR | 1.00 |
Earnings ESP
|
-7.02% |
---|---|
Current Year | -2.29 |
Next Year | -3.07 |
EPS (TTM) | -1.79 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.61M | 10.28M | 45.09M | 14.37M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 14.49M | 14.49M | 55.16M | 23.80M |
Low Estimate | 6.25M | 5.25M | 31.59M | 3.16M |
Year ago Sales | 15.20M | 14.03M | 46.02M | 45.09M |
Year over Year Growth Est. | -30.18% | -26.73% | -2.02% | -68.14% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.57 | -0.61 | -2.29 | -3.07 |
# of Estimates | 4 | 3 | 6 | 5 |
Most Recent Consensus | -0.48 | -0.48 | -1.99 | -2.42 |
High Estimate | -0.48 | -0.48 | -1.99 | -2.42 |
Low Estimate | -0.67 | -0.70 | -2.52 | -3.44 |
Year ago EPS | -0.33 | -0.33 | -1.82 | -2.29 |
Year over Year Growth Est. | -72.73% | -84.85% | -25.82% | -34.03% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 1 | 1 | 2 | 3 |
Down Last 30 Days | 1 | 1 | 2 | 3 |
Down Last 60 Days | 1 | 1 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.57 | -0.61 | -2.29 | -3.07 |
7 Days Ago | -0.55 | -0.60 | -2.22 | -2.91 |
30 Days Ago | -0.55 | -0.60 | -2.22 | -2.91 |
60 Days Ago | -0.55 | -0.60 | -2.22 | -2.91 |
90 Days Ago | -0.47 | -0.60 | -2.05 | -2.97 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.61 | -0.70 | -2.44 | -3.19 |
Zacks Consensus Estimate | -0.57 | -0.61 | -2.29 | -3.07 |
Earnings ESP | -7.02% | -15.38% | -6.70% | -3.94% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.58 | -0.55 | -0.33 | -0.33 | NA |
Estimate | -0.55 | -0.34 | -0.60 | -0.62 | NA |
Difference | -0.03 | -0.21 | 0.27 | 0.29 | 0.08 |
Surprise | -5.45% | -61.76% | 45.00% | 46.77% | 6.14% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more